Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
J Dtsch Dermatol Ges ; 19(3): 479-494, 2021 03.
Article in English | MEDLINE | ID: mdl-33634583

ABSTRACT

Anogenital and oropharyngeal infections with human papilloma viruses (HPV) are common. Clinically manifest disease may significantly impact quality of life; the treatment of HPV-associated lesions is associated with a high rate of recurrence and invasive neoplasms, such as cervical, anal, vulvar, penile, and oropharyngeal cancers, which are characterized by significant morbidity and mortality. Vaccination against HPV is an effective and safe measure for the primary prevention of HPV-associated lesions, but immunization rates are still low in Germany. The present publication is an abridged version of the German evidence and consensus-based guideline "Vaccination recommendations for the prevention of HPV-associated lesions", which is available on the website of the German Association of the Scientific Medical Societies (AWMF). On the basis of a systematic review with meta-analyses, a representative panel developed and agreed upon recommendations for the vaccination of different populations against HPV. In addition, consensus-based recommendations were developed for specific issues relevant to everyday practice. Based on current evidence and a representative expert consensus, these recommendations are intended to provide guidance in a field in which there is often uncertainty and in which both patients and health care providers are sometimes confronted with controversial and emotionally charged points of view.


Subject(s)
Papillomaviridae , Papillomavirus Infections , Consensus , Humans , Papillomavirus Infections/prevention & control , Quality of Life , Vaccination
2.
J Dtsch Dermatol Ges ; 18(1): 55-78, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31951098

ABSTRACT

The present guidelines are aimed at residents and board-certified specialists in the fields of dermatology, ophthalmology, ENT, pediatrics, neurology, virology, infectious diseases, anesthesiology, general medicine and any other medical specialties involved in the management of patients with herpes zoster. They are also intended as a guide for policymakers and health insurance funds. The guidelines were developed by dermatologists, virologists, ophthalmologists, ENT physicians, neurologists, pediatricians and anesthesiologists/pain specialists using a formal consensus process (S2k). Readers are provided with an overview of the clinical and molecular diagnostic workup, including antigen detection, antibody tests and viral culture. Special diagnostic situations and complicated disease courses are discussed. The authors address general and special aspects of antiviral therapy for herpes zoster and postherpetic neuralgia. Furthermore, the guidelines provide detailed information on pain management including a schematic overview, and they conclude with a discussion of topical treatment options.


Subject(s)
Analgesics/therapeutic use , Antiviral Agents/therapeutic use , Herpes Zoster/diagnosis , Herpes Zoster/drug therapy , Neuralgia, Postherpetic/diagnosis , Neuralgia, Postherpetic/drug therapy , Administration, Topical , Antibodies, Viral/blood , Antibodies, Viral/cerebrospinal fluid , Herpes Zoster/complications , Herpesvirus 3, Human/immunology , Herpesvirus 3, Human/isolation & purification , Humans , Neuralgia, Postherpetic/etiology , Pain Management , Risk Factors
3.
J Neurol Neurosurg Psychiatry ; 87(3): 302-10, 2016 Mar.
Article in English | MEDLINE | ID: mdl-25817520

ABSTRACT

OBJECTIVE: The results of register studies suggest an association between Parkinson's disease (PD) and melanoma. We studied the frequency and profile of early markers of PD in patients with malignant melanoma. METHODS: 100 participants were enrolled in a prospective observational study, of whom 65 had a history of high-risk cutaneous (n=53) or uveal (n=12) melanoma (31 women; age, 61.2±14.9 years) and another 35 served as control participants (19 women; 54.6±20.5 years). Participants underwent assessments of motor function (Unified PD Rating Scale; keyboard tapping test), olfactory function, colour vision, depressive symptoms, the Non-Motor Symptoms Questionnaire, and transcranial brain sonography. Raters were blinded to the diagnosis and clinical data of study participants. RESULTS: Patients with melanoma showed increased frequency of substantia nigra hyperechogenicity and prodromal motor and non-motor features of PD, especially asymmetric motor slowing and apathy. Hyposmia and colour vision disturbance were, however, infrequent. Larger echogenicity of substantia nigra correlated with lower serum iron in patients with melanoma, similar to previously reported findings in PD, and independently from the earlier findings, with lighter skin pigmentation. Substantia nigra hyperechogenicity, combined with motor asymmetry or hyposmia, was present at baseline in all participants with mild or definite parkinsonism diagnosed after 1 year. Parkinsonism was specifically related to melanoma location at the sun-exposed skin of the head or neck. CONCLUSIONS: History of melanoma was associated with increased prevalence of prodromal markers of PD. Their predictive value needs to be established in long-term investigations. The similarity of serum iron characteristics found in patients with melanoma and PD deserves further research.


Subject(s)
Melanoma/epidemiology , Parkinson Disease/diagnosis , Parkinson Disease/epidemiology , Prodromal Symptoms , Case-Control Studies , Comorbidity , Female , Humans , Male , Melanoma/diagnostic imaging , Middle Aged , Parkinson Disease/diagnostic imaging , Prevalence , Prospective Studies , Ultrasonography, Doppler, Transcranial
6.
J Cutan Pathol ; 40(11): 935-44, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24102613

ABSTRACT

BACKGROUND: Nephrogenic systemic fibrosis (NSF) represents a rare fibrosing disorder occurring after administration of gadolinium-containing contrast agents during renal insufficiency. In order to prove the effect of gadolinium elimination on clinical signs, we identified and quantified gadolinium in skin biopsies of a 62-year-old patient with NSF with regard to improving skin lesions after recovery of renal function. METHODS: Gadolinium deposits were visualized and identified in NSF skin biopsies by light microscopy and transmission electron microscopy (EM) and by scanning EM. Inductively coupled plasma-mass spectrometry (ICPMS) was used for quantifying gadolinium concentration. RESULTS: Transmission EM studies revealed electron-dense material in connective matrix around blood vessels and inside lysosomes of histiocytes and fibroblasts. A remarkable reduction of gadolinium deposits was observed in transmission EM and scanning EM and confirmed by ICPMS in follow-up biopsies. After spontaneous recovery of renal function, his skin induration improved notably over the next 2 years. CONCLUSIONS: The reduction of clinical and histomorphological signs of NSF correlated with decreasing gadolinium concentration in skin biopsies within 3 years. Our study suggests a possible pathogenetic mechanism of NSF including a chance for recovery after elimination of gadolinium and reduced histamine liberation by mast cells.


Subject(s)
Contrast Media/adverse effects , Gadolinium/adverse effects , Nephrogenic Fibrosing Dermopathy/chemically induced , Nephrogenic Fibrosing Dermopathy/pathology , Skin/chemistry , Contrast Media/analysis , Gadolinium/analysis , Humans , Magnetic Resonance Imaging , Male , Microscopy, Electron , Middle Aged , Renal Insufficiency/diagnosis , Skin/pathology , Time
9.
GMS Infect Dis ; 8: Doc01, 2020.
Article in German | MEDLINE | ID: mdl-32373426

ABSTRACT

This guideline is aimed at registrars and consultants in dermatology, ophthalmology, ENT, pediatrics, neurology, virology as well as infectiology, anaesthesia and generell medicine as well as policymakers and payers and purchasers of care. It was developed by dermatologists, virologists, ophthalmologists, ENT physicians, neurologists, pediatrician and anesthetists using a formal consensus process (S2k).The guideline provides an overview of clinical and molecular diagnostics as well as antigen detection, antibody culture and viral culture. Diagnostic special situations and complicated courses of the disease are also considered. The antiviral therapy of zoster and postzoster neuralgia is presented in general and for special situations. Detailed information on the treatment of pain is mentioned and presented in an overview. Likewise, the local therapeutic measures are discussed.

10.
AJR Am J Roentgenol ; 190(3): 666-70, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18287437

ABSTRACT

OBJECTIVE: Contrast material is generally well tolerated although approximately 1% of patients who receive low-osmolar nonionic contrast material will develop anaphylaxis symptoms. Because most anaphylactic reactions are mild and nonallergic, clinically mimicking immunoglobulin E (IgE)-mediated allergy, diagnostic skin testing has been discussed controversially in the past and prophylactic pretreatment drug regimens are recommended instead. In the past 6 years, all patients with contrast material-induced anaphylaxis have been subjected to allergologic diagnostic procedures to clearly differentiate allergic and nonallergic anaphylaxis. Thus the purpose of our study was to identify and differentiate IgE-mediated allergy and nonallergic contrast material-induced hypersensitivity. Furthermore, the objective of our diagnostic procedures was not only to identify the culprit contrast material but also to find alternative contrast material for future radiologic interventions. SUBJECTS AND METHODS: We evaluated 96 patients with anaphylaxis symptoms after contrast material application using standardized intradermal skin testing. In patients with positive skin tests, the IgE-mediated allergy was further evaluated with in vitro and challenge tests. RESULTS: In four patients (suffering from anaphylaxis grades 2 and 3) out of the 96 (4.2%), skin tests and basophil activation tests strongly suggested IgE-mediated allergy to the contrast materials iopromide (two patients), iomeprol, and iopentol. In two patients with allergies to iopromide and iomeprol, alternative nonionic monomer contrast materials were tolerated, as identified in controlled challenge tests with iopamidol and iopromide, respectively. CONCLUSION: The evaluation of patients with contrast material-induced anaphylaxis (at least those with anaphylaxis > or = grade 2) should always include appropriate skin tests ensuring that patients with an IgE-mediated allergy are not missed. Moreover, allergologic testing may identify a contrast material of the group of nonionic monomers that will be tolerated in future radiologic interventions.


Subject(s)
Anaphylaxis/diagnosis , Contrast Media/adverse effects , Immunoglobulin E/physiology , Adult , Aged , Aged, 80 and over , Anaphylaxis/chemically induced , Anaphylaxis/immunology , Basophil Degranulation Test , Cohort Studies , Diagnostic Imaging , Female , Halogenation , Humans , Iohexol/adverse effects , Iohexol/analogs & derivatives , Iopamidol/adverse effects , Iopamidol/analogs & derivatives , Male , Middle Aged , Skin Tests , Triiodobenzoic Acids/adverse effects
11.
Ultrastruct Pathol ; 31(6): 379-84, 2007.
Article in English | MEDLINE | ID: mdl-18098055

ABSTRACT

Five patients with generalized slate-gray discoloration of the skin have been diagnosed histologically as argyria in the last 35 years in the Department of Dermatology and Venereology of Rostock and Halle. Light microscopically, there was visible black pigmentation in histiocytes, fibroblasts, and multinucleated giant cells of the dermis. In the transmission electron microscope (TEM), the authors observed electron-dense deposits inside lysosomes and residual bodies of phagocytes as well as outside the cells in the connective matrix. These deposits were identified by elemental analysis in TEM and electron energy loss spectroscopy (EELS) as well as scanning electron microscope (SEM) and energy dispersive x-ray analysis (EDX) containing silver and sulfur. Therefore, they seem to consist of silver sulfide. Argyria is of low medical relevance and is very rarely induced because of silver-containing drugs. Nevertheless, there are still a lot of silver products on the market, easily available over-the-counter. Therefore, argyria should not be forgotten or missed in the diagnostics of human dermis.


Subject(s)
Argyria/metabolism , Silver Compounds/metabolism , Silver Nitrate/therapeutic use , Skin/metabolism , Colloids/chemistry , Electron Probe Microanalysis/methods , Female , Humans , Lysosomes/chemistry , Lysosomes/ultrastructure , Male , Microscopy, Electron, Scanning/methods , Microscopy, Energy-Filtering Transmission Electron/methods , Phagocytes/chemistry , Phagocytes/ultrastructure , Proteins/chemistry , Silver/chemistry , Skin/ultrastructure
13.
J Antimicrob Chemother ; 60(1): 107-11, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17510067

ABSTRACT

OBJECTIVES: Aminopenicillin-induced exanthema poses a problem in the management of infectious diseases. Due to theoretically possible immunological cross-reactivity, all beta-lactam drugs, i.e. penicillins, penicillin derivatives and cephalosporins, are usually avoided. The available alternative antibiotics (macrolides, quinolones and glycopeptides) may be less effective, have more side effects, and their use increases medical costs. Moreover, their use contributes to the increasing bacterial resistance to antibiotics. The aim of the study is to demonstrate that patients with aminopenicillin-induced exanthema may receive specific beta-lactams for future antibiotic therapy. METHODS: Skin testing followed by oral challenges to identify beta-lactams that are tolerated by patients despite confirmed delayed-type non-immunoglobulin E (IgE)-mediated allergic hypersensitivity to aminopenicillins. RESULTS: Sixty-nine out of 71 patients (97.2%) with non-IgE-mediated allergic hypersensitivity to aminopenicillins tolerate cephalosporins without an aminobenzyl side chain such as cefpodoxime or cefixime and 51 patients (71.8%) also tolerate phenoxymethyl penicillin. CONCLUSIONS: The majority of patients with non-IgE-mediated allergic hypersensitivity to aminopenicillins do not cross-react to certain cephalosporins or phenoxymethyl penicillin. Skin and drug challenge tests can be helpful to determine individual cross-reactivity.


Subject(s)
Amoxicillin/adverse effects , Anti-Bacterial Agents/therapeutic use , Cephalosporins/therapeutic use , Drug Hypersensitivity/drug therapy , Exanthema/drug therapy , Hypersensitivity, Delayed/drug therapy , Penicillin V/therapeutic use , Adolescent , Adult , Aged , Cefixime/adverse effects , Cefixime/chemistry , Cefixime/therapeutic use , Ceftizoxime/adverse effects , Ceftizoxime/analogs & derivatives , Ceftizoxime/therapeutic use , Cephalosporins/chemistry , Cross Reactions , Drug Hypersensitivity/etiology , Exanthema/chemically induced , Female , Humans , Hypersensitivity, Delayed/etiology , Immunoglobulin E/blood , Male , Middle Aged , Penicillin V/chemistry , Single-Blind Method , Skin Tests , Treatment Outcome , beta-Lactams/chemistry , beta-Lactams/therapeutic use , Cefpodoxime
SELECTION OF CITATIONS
SEARCH DETAIL